Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Edmund

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Pharmaceutical Research|September 1, 2005
(99m)Tc-EC-guanine: synthesis, biodistribution, and tumor imaging in animalsDavid J Yang, Kaoru Ozaki, Chang-Sok Oh, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Assessment of therapeutic tumor response using 99mtc-ethylenedicysteine-glucosamineDavid Yang, Masashi Yukihiro, Dong-Fang Yu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 4, 2019
Prognostic value of metabolic tumour volume on baseline <sup>18</sup>F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPIQaid Ahmed Shagera, Gi Jeong Cheon, Youngil Koh, et al.
Annals of Nuclear Medicine|July 3, 2013
Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomyHai-Jeon Yoon, Jin Chul Paeng, Cheol Kwak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 7, 2014
Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysisHyung-Jun Im, Kyoungjune Pak, Gi Jeong Cheon, et al.
Nuclear Medicine and Molecular Imaging|June 6, 2014
Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary StudySoo Jin Lee, Hyo Jung Seo, Gi Jeong Cheon, et al.
Clinical Nuclear Medicine|June 9, 2016
Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRIYong-Il Kim, Hai-Jeon Yoon, Jin Chul Paeng, et al.
Cancer|August 25, 2005
Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinomaDavid Hong, Simon Lunagomez, E Edmund Kim, et al.
Medicine|May 14, 2016
Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic CancerHyung-Jun Im, Suthet Oo, Woohyun Jung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasiaIsis W Gayed, E Edmund Kim, William F Broussard, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Pharmaceutical Research|September 1, 2005
(99m)Tc-EC-guanine: synthesis, biodistribution, and tumor imaging in animalsDavid J Yang, Kaoru Ozaki, Chang-Sok Oh, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Assessment of therapeutic tumor response using 99mtc-ethylenedicysteine-glucosamineDavid Yang, Masashi Yukihiro, Dong-Fang Yu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 4, 2019
Prognostic value of metabolic tumour volume on baseline <sup>18</sup>F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPIQaid Ahmed Shagera, Gi Jeong Cheon, Youngil Koh, et al.
Annals of Nuclear Medicine|July 3, 2013
Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomyHai-Jeon Yoon, Jin Chul Paeng, Cheol Kwak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 7, 2014
Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysisHyung-Jun Im, Kyoungjune Pak, Gi Jeong Cheon, et al.
Nuclear Medicine and Molecular Imaging|June 6, 2014
Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary StudySoo Jin Lee, Hyo Jung Seo, Gi Jeong Cheon, et al.
Clinical Nuclear Medicine|June 9, 2016
Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRIYong-Il Kim, Hai-Jeon Yoon, Jin Chul Paeng, et al.
Cancer|August 25, 2005
Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinomaDavid Hong, Simon Lunagomez, E Edmund Kim, et al.
Medicine|May 14, 2016
Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic CancerHyung-Jun Im, Suthet Oo, Woohyun Jung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasiaIsis W Gayed, E Edmund Kim, William F Broussard, et al.
Pageof 9